Grant: $280,869 - National Institutes of Health - Aug. 13, 2009
No votes have been cast for this award yet
Award Description: Malfunction of the spindle checkpoint has been implicated in human cancers. The class of antimitotic anti-cancer drugs, such as Taxol, kills cancer cells by exploiting defects in this pathway. The proposed experiments will shed light on the molecular basis of the spindle checkpoint, which might eventually lead to new strategies to treat human cancers.
Project Description: The overall goal of this supplement is to retain and hire additional personnels to speed up the pace of our research. We have used a large portion of this fund to pay for the salary and fringe benefit of Dr. Jungseog, a senior member of my research team. Dr. Kang has made numerous exciting discoveries in my lab. He is currently investigating the connection of heterochromatin protein 1 (HP1) and Sgo1. In the application, we have requested fund to hire a junior technician and cover 60% of his/her salary. We have initiated this process and interviewed several candidates. We expect to fill this position by the end of this year.
Jobs Summary: This fund has allowed us to retain Dr. Jungseog Kang, an Assistant Instructor, on this project. Dr. Kang has more than 10 years of research experience in chromosome biology. He is an integral part of my research team. Retaining him will enable us to maintain our current momentum of discovery. (Total jobs reported: 1)
Project Status: More than 50% Completed
This award's data was last updated on Aug. 13, 2009. Help expand these official descriptions using the wiki below.